JP2023535527A - 抗菌活性を有する化合物 - Google Patents

抗菌活性を有する化合物 Download PDF

Info

Publication number
JP2023535527A
JP2023535527A JP2023524493A JP2023524493A JP2023535527A JP 2023535527 A JP2023535527 A JP 2023535527A JP 2023524493 A JP2023524493 A JP 2023524493A JP 2023524493 A JP2023524493 A JP 2023524493A JP 2023535527 A JP2023535527 A JP 2023535527A
Authority
JP
Japan
Prior art keywords
alkyl
group
cycloalkyl
aryl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023524493A
Other languages
English (en)
Japanese (ja)
Inventor
ゼメル ギタイ、
ハーン キム、
ジェイムズ ケー． マーチン、
ジョセフ ピー． シーハン、
コナー チェイン、
ヨン フアン、
シュオ リ、
シェミン チェン、
チェンラン ジアン、
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Princeton University
Original Assignee
Princeton University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Princeton University filed Critical Princeton University
Publication of JP2023535527A publication Critical patent/JP2023535527A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2023524493A 2020-07-02 2021-07-01 抗菌活性を有する化合物 Pending JP2023535527A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063047612P 2020-07-02 2020-07-02
US63/047,612 2020-07-02
PCT/US2021/040143 WO2022006432A1 (en) 2020-07-02 2021-07-01 Compounds having antibacterial activity

Publications (1)

Publication Number Publication Date
JP2023535527A true JP2023535527A (ja) 2023-08-17

Family

ID=79314944

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023524493A Pending JP2023535527A (ja) 2020-07-02 2021-07-01 抗菌活性を有する化合物
JP2022581398A Pending JP2023532128A (ja) 2020-07-02 2021-07-01 抗がん作用を有する化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022581398A Pending JP2023532128A (ja) 2020-07-02 2021-07-01 抗がん作用を有する化合物

Country Status (7)

Country Link
US (2) US20230295164A1 (https=)
EP (2) EP4175953A4 (https=)
JP (2) JP2023535527A (https=)
CN (2) CN115867354B (https=)
AU (2) AU2021299504A1 (https=)
CA (2) CA3183770A1 (https=)
WO (2) WO2022006432A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11963959B2 (en) * 2021-08-17 2024-04-23 Southwest Research Institute Inhibitors for coronavirus
WO2024077235A2 (en) * 2022-10-07 2024-04-11 The Trustees Of Princeton University Dihydrofolate reductase inhibitors for anti-biotic resistant infections
CN118047780A (zh) * 2022-11-09 2024-05-17 中国医学科学院药物研究所 一类喹唑啉杂环化合物及其抗感染和抗肿瘤的应用
CN119661535B (zh) * 2023-09-21 2026-03-20 中国医学科学院药物研究所 7H-吡咯并[3,2-f]喹唑啉衍生物及其抗感染应用
WO2025194625A1 (zh) * 2024-03-22 2025-09-25 深圳湾实验室坪山生物医药研发转化中心 结核病的预防与治疗
WO2025195460A1 (zh) * 2024-03-22 2025-09-25 深圳湾实验室坪山生物医药研发转化中心 稠环衍生物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS539796A (en) * 1976-07-09 1978-01-28 American Home Prod 77substitutedd7hhpyrrolo *3*22f* quinasolinee1*33 diamines
US20140329840A1 (en) * 2013-05-06 2014-11-06 Georgia Tech Research Corporation Molecules with potent dhfr binding affinity and antibacterial activity
US20190201401A1 (en) * 2017-08-01 2019-07-04 The Trustees Of Princeton University Compounds having antibacterial activity and methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4118561A (en) * 1977-04-06 1978-10-03 American Home Products Corporation 7-(Substituted)-7H-pyrrolo[3,2-f]quinazoline-1,3-diamines
JP2005500253A (ja) * 2001-02-23 2005-01-06 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド トロンビン受容体アンタゴニストとしてのアミノメチルピロロキナゾリン化合物
US7253177B2 (en) * 2004-10-22 2007-08-07 United States Of America As Represented By The Secretary Of The Army Synthesis and antimalarial activity of pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives
EP3010923A4 (en) * 2013-06-20 2016-12-14 Univ Oregon Health & Science PYRROLOCHINAZOLINVERBINDUNGEN
WO2015173802A1 (en) * 2014-05-11 2015-11-19 Tel Hashomer Medical Research Infrastructure And Services Ltd. Par-1 based therapeutic conjugates and uses thereof
US20210161900A1 (en) * 2018-04-30 2021-06-03 Duke University Compositions and methods for the treatment of senescent tumor cells
CN114514230A (zh) * 2019-08-20 2022-05-17 希望之城 Mettl16抑制剂及其用途

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS539796A (en) * 1976-07-09 1978-01-28 American Home Prod 77substitutedd7hhpyrrolo *3*22f* quinasolinee1*33 diamines
US20140329840A1 (en) * 2013-05-06 2014-11-06 Georgia Tech Research Corporation Molecules with potent dhfr binding affinity and antibacterial activity
US20190201401A1 (en) * 2017-08-01 2019-07-04 The Trustees Of Princeton University Compounds having antibacterial activity and methods of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 9, JPN6025019831, 1999, pages 2073 - 2078, ISSN: 0005597674 *

Also Published As

Publication number Publication date
EP4175958A1 (en) 2023-05-10
CA3183776A1 (en) 2022-01-06
JP2023532128A (ja) 2023-07-26
EP4175953A4 (en) 2024-08-14
CN115867354B (zh) 2025-08-26
CN116234808A (zh) 2023-06-06
AU2021301264A1 (en) 2023-02-02
EP4175953A1 (en) 2023-05-10
US20230295164A1 (en) 2023-09-21
CN116234808B (zh) 2025-11-14
EP4175958A4 (en) 2024-07-17
WO2022006447A1 (en) 2022-01-06
US20230242540A1 (en) 2023-08-03
CN115867354A (zh) 2023-03-28
CA3183770A1 (en) 2022-01-06
AU2021299504A1 (en) 2023-02-02
WO2022006432A1 (en) 2022-01-06

Similar Documents

Publication Publication Date Title
JP2023535527A (ja) 抗菌活性を有する化合物
CA2103861C (en) Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines
US5602277A (en) Substituted benzene derivatives useful as neuraminidase inhibitors
EA013819B1 (ru) Аминометилзамещенные тетрациклиновые соединения
EP0807630B1 (en) Heterocyclic compounds
CN1471509A (zh) 9-取代的二甲胺四环素化合物
KR100232937B1 (ko) 피리돈카복실산 유도체 및 이를 함유하는 항균제
WO2020163479A1 (en) Antibiotic ammonium compounds and methods for the treatment of bacterial infections
HUP0103316A2 (hu) 2-Ureido-pirimidon-származékok, eljárás azok előállítására, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
RU2737085C2 (ru) Новое соединение 2,4,6-тризамещенного s-триазина, способ его получения и его применение
EP2957561A1 (en) Novel fluoroquinolones and use thereof to treat bacterial infections
KR102381397B1 (ko) 신규 나프토퀴논 유도체 화합물 및 이를 포함하는 항균용 조성물
Moise et al. Synthesis and antimicrobial activity of some new (sulfon-amidophenyl)-amide derivatives of N-(4-nitrobenzoyl)-phenylglycine and N-(4-nitrobenzoyl)-phenylalanine
CN103025722B (zh) 具有2-(杂芳基)氨基取代基的氯苯吩嗪及其抗微生物活性
Bouchareb et al. Synthesis and antibacterial activity of new chiral N-sulfamoyloxazolidin-2-ones
CN109988157B (zh) 新型小分子化合物、制备方法及在制备抗耐药结核分枝杆菌等分枝杆菌药物方面的用途
CN109705015B (zh) 组蛋白去乙酰化酶抑制剂及其制备方法与用途
ES2588597T3 (es) Compuestos que presentan actividad antibacteriana, procedimientos utilizables en su preparación y composiciones farmacéuticas que los comprenden
Isakhanyan et al. Synthesis and antibacterial activity of new 4-(2-phenyl-4-quinolylcarbamoyl) benzoic acid derivatives
KR102765205B1 (ko) 항독력 활성을 가지는 철 킬레이트 화합물 및 이의 용도
JP7630179B2 (ja) 細菌感染症を治療するためのペナム誘導体
KR102877382B1 (ko) 신규 알카인 케톤 유도체 및 이를 유효성분으로 포함하는 세균 감염병의 예방 또는 치료용 약학 조성물
RU2179971C2 (ru) Диэтиламмониевая соль n-бензилиденамино-1-фенилметансульфоновой кислоты, обладающая бактерицидной активностью, и способ ее получения
EP4525852A1 (en) Inhibitors of msba as antibiotics, pharmaceutical compositions, and uses thereof
CN115246819A (zh) 芳基连二咪唑类化合物、制备方法及其医药用途

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240625

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250515

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250520

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250819

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251119

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20260303